hept-6-yn-1-yl methanesulfonate | 93131-30-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: hept-6-yn-1-yl methanesulfonate
• 英文别名: hept-6-ynyl methanesulfonate
• CAS: 93131-30-7
• 化学式: C₈H₁₄O₃S
• 分子量: 190.263
• InChiKey: FUNSIYQMQAJOGB-UHFFFAOYSA-N

物化性质

• 沸点：
  316.7±25.0 °C(Predicted)
• 密度：
  1.107±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  51.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  hept-6-yn-1-yl methanesulfonate 在 sodium azide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以36 g的产率得到7-azidohept-1-yne
  参考文献：
  名称：

  [EN] TYK2 DEGRADERS AND USES THEREOF
  [FR] AGENTS DE DÉGRADATION DE TYK2 ET LEURS UTILISATIONS

  摘要：

  The present invention provides compounds, compositions thereof, and methods of using the same. Compounds and compositions thereof that are useful, for example, for targeting, inhibiting, and/or degrading TYK2. In certain embodiments, provided are TYK2 inhibitors and/or degraders and methods of making same. More specifically, TYK2 degraders, compositions which comprise TYK2 degraders, and methods of treating TYK2-associated conditions are provided.

  公开号：

  WO2023076161A1
• 作为产物：
  描述：

  6-庚炔醇 生成 hept-6-yn-1-yl methanesulfonate
  参考文献：
  名称：

  Vinyl cations. 40. .pi.- and .sigma.-Routes to vinyl cations. Solvolyses of 2-methylcyclohexenyl, cyclopentylideneethyl, hex-5-yn-1-yl, and related triflates

  摘要：

  DOI：

  10.1021/ja00350a044

文献信息

• DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE AND PHARMACEUTICALS CONTAINING THE SAME
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：US20160002251A1

  公开（公告）日：2016-01-07

  The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification comprising the compound as an active ingredient, and a method for prevention and/or treatment.

  本发明提供了一种二氢吡啶嗪-3,5-二酮衍生物或其盐，或化合物或盐的溶剂化合物，一种药物，一种药物组合物，一种钠依赖性磷酸盐转运体抑制剂，以及作为活性成分的化合物的高磷血症、继发性甲状旁腺功能亢进症、慢性肾功能衰竭、慢性肾病和与血管钙化相关的动脉硬化的预防和/或治疗剂，以及预防和/或治疗的方法。
• Copper-Catalyzed <i>Anti</i>-Markovnikov Hydrosilylation of Terminal Alkynes
  作者：Zi-Lu Wang、Feng-Lian Zhang、Jian-Lin Xu、Cui-Cui Shan、Meng Zhao、Yun-He Xu

  DOI：10.1021/acs.orglett.0c02952

  日期：2020.10.2

  A copper-catalyzed anti-Markovnikov hydrosilylation of alkynes with PhSiH3 was reported. This reaction represents a notable and efficient example on copper-catalyzed hydrosilylatioin of alkynes, which shows excellent recognition between the terminal and internal triple bonds. Various (hetero)aromatic and aliphatic substituted terminal alkynes underwent this reaction to afford the (E)-vinylsilanes in

  据报道，用PhSiH 3对炔烃进行铜催化的反Markovnikov氢化硅烷化。该反应代表了炔烃在铜催化的氢甲硅烷基化上的显着且有效的实例，该化合物在末端和内部三键之间表现出出色的识别性。使各种（杂）芳族和脂族取代的末端炔烃进行该反应，以高收率和优异的区域选择性提供（E）-乙烯基硅烷。
• Intramolecular cyclization mediated by silylmetalation of acetylenes with PhMe2SiMgMe/CuI and radical nature of the reagent
  作者：Yasuhiro Okuda、Yoshitomi Morizawa、Koichiro Oshima、Hitosi Nozaki

  DOI：10.1016/s0040-4039(01)81210-7

  日期：1984.1

  Whereas CuI catalyzed silylmagnesation of the tosylate of 5- hexyn-l-ol with the title reagent affords dimethylphenylsilylmethylenecyclopentane exclusively, the mesylate of 3-butyn-l-ol gives a mixture of unexpected silylcyclobutene and cyclopropylidene derivative.

  CuI用标题试剂催化的5-己炔-1-醇的甲苯磺酸酯的甲硅烷基镁仅得到二甲基苯基甲硅烷基亚甲基环戊烷，而3-丁炔-1-醇的甲磺酸酯则得到了意想不到的甲硅烷基环丁烯和环亚丙基衍生物的混合物。
• Isolation, Synthesis and Absolute Configuration of the Pericharaxins A and B, Epimeric Hydroxy-Polyene Glycerol Ethers from the Calcarean Sponge Pericharax heteroraphis
  作者：Capucine Jourdain de Muizon、Céline Moriou、Sylvain Petek、Merrick Ekins、Marthe Rousseau、Ali Al Mourabit

  DOI：10.3390/md20100635

  日期：——

  epimeric hydroxy-polyene glycerol ether pericharaxins A (1a) and B (1b) were isolated from the calcarean sponge Pericharax heteroraphis. The structural and stereochemical characterization of both diastereoisomers were established on the basis of spectroscopic data analysis and total synthesis in seven steps. The mixture of pericharaxins A (1a) and B (1b) was proven to be epimeric by chiral-phase HPLC analysis

  从钙质海绵Pericharax heteroraphis中分离出天然存在的差向异构羟基多烯甘油醚 pericharaxins A ( 1a ) 和 B ( 1b ) 。在光谱数据分析和七步全合成的基础上，建立了两种非对映异构体的结构和立体化学表征。Pericharaxins A ( 1a ) 和 B ( 1b ) 的混合物) 通过合成和天然样品的手性相 HPLC 分析证明是差向异构体。差向异构体的进一步分离和 Mosher 方法对合成化合物的应用允许明确的绝对构型分配。虽然天然产物和合成中间体显示对 HCT116 细胞系无细胞毒性，但在 ATDC5 细胞中使用人 X 型胶原转录活性的软骨内分化活性是有趣的。
• DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE
  申请人：Chugai Seiyaku Kabushiki Kaisha

  公开号：EP2975030A1

  公开（公告）日：2016-01-20

  The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure, comprising the compound as an active ingredient, and a method for prevention and/or treatment.

  本发明提供了一种二氢哒嗪-3,5-二酮衍生物或其盐，或该化合物或该盐的溶液剂、一种药物、一种药物组合物、一种钠依赖性磷酸盐转运体抑制剂，以及一种预防和/或治疗高磷血症、继发性甲状旁腺功能亢进症和慢性肾功能衰竭的药物，其中包含该化合物作为活性成分，以及一种预防和/或治疗方法。